REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,040
-50 (-0.50%)
Sep 11, 2026, 3:30 PM KST

REYON Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,0186,66710,20924,10716,04966,741
Short-Term Investments
----20,00030,380
Trading Asset Securities
18.72115.036.05134.0219.83327.64
Cash & Short-Term Investments
7,0366,78210,21524,24136,06997,448
Cash Growth
-18.57%-33.61%-57.86%-32.79%-62.99%114.32%
Accounts Receivable
34,07634,38136,72039,92741,81040,465
Other Receivables
599.84299.59442.4450.98238.02384.38
Receivables
34,67634,68037,16239,97842,04840,850
Inventory
36,68337,93041,99135,17630,10926,432
Prepaid Expenses
146.5177.7528.03229.5728.5332.51
Other Current Assets
-0195.1447.67188.61751.8941.89
Total Current Assets
78,54279,66589,44399,813109,006164,804
Property, Plant & Equipment
349,446361,230384,397368,342340,568281,156
Long-Term Investments
10,61218,93116,01121,21626,21124,557
Other Intangible Assets
666.381,4801,8031,3921,4041,427
Long-Term Deferred Tax Assets
1,324-4,4085,0754,1042,004
Long-Term Deferred Charges
2,8002,8002,8002,8002,8002,800
Other Long-Term Assets
980.01993.891,1311,137598.411,230
Total Assets
444,370465,100499,994499,776484,692477,978

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,6908,65910,0288,1864,7934,731
Accrued Expenses
3,3343,2693,5133,7763,6462,253
Short-Term Debt
108,006101,46481,20194,65622,50022,500
Current Portion of Long-Term Debt
17,50014,0008,0006,000--
Current Portion of Leases
1,338951.941,4581,6102,2541,911
Current Income Taxes Payable
284.37--852.4733.48426.48
Other Current Liabilities
20,19814,98731,33610,52214,02515,682
Total Current Liabilities
158,350143,331135,537125,60247,95147,503
Long-Term Debt
89,50099,000113,000121,000184,218182,425
Long-Term Leases
509.05698.76392.91,7881,231478.19
Long-Term Deferred Tax Liabilities
-656.4665.8412.95-7.09
Other Long-Term Liabilities
1,1411,1411,0572,7483,5262,328
Total Liabilities
249,500244,827250,053251,151236,926232,741

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
9,2939,2939,2939,2938,9998,999
Additional Paid-In Capital
38,95538,95538,95538,95539,00339,003
Retained Earnings
160,223177,764207,397205,997205,151202,281
Treasury Stock
-5,079-5,079-5,078-5,079-5,079-5,079
Comprehensive Income & Other
-8,522-660.39-626-541.75-559.4-217.03
Total Common Equity
194,870220,273249,941248,625247,515244,987
Shareholders' Equity
194,870220,273249,941248,625247,765245,237
Total Liabilities & Equity
444,370465,100499,994499,776484,692477,978

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
216,853216,115204,053225,054210,203207,314
Net Cash (Debt)
-209,816-209,333-193,838-200,813-174,134-109,866
Net Cash Growth
------
Net Cash Per Share
-11439.74-11413.42-10568.57-10948.85-9538.14-6200.33
Filing Date Shares Outstanding
18.3418.3418.3418.3417.7517.75
Total Common Shares Outstanding
18.3418.3418.3418.3418.2517.75
Working Capital
-79,808-63,666-46,093-25,78961,055117,301
Book Value Per Share
10624.8212009.8713627.4613555.6813560.4313799.95
Tangible Book Value
194,203218,793248,138247,233246,111243,561
Tangible Book Value Per Share
10588.4911929.1713529.1513479.7913483.5113719.59
Land
12,36212,36212,36212,36212,36212,362
Buildings
209,537209,537209,53712,71212,71212,712
Machinery
169,760169,264166,01743,93942,51939,530
Construction In Progress
52,39449,55445,487342,022314,018256,737